{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O75888",
      "entity_text" : "April",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:8021",
      "entity_text" : "DEA",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Although DEA increased quotas for manufacturing of controlled substances on April 17, 2020, the ability to upscale the manufacturing process is limited due to the aforementioned manufacturing issues.",
  "reading_complete" : "2020-08-04T13:35:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:34:11Z",
  "trigger" : "increased",
  "evidence" : [ "DEA increased quotas for manufacturing of controlled substances on April" ],
  "pmc_id" : "7250588",
  "score" : 0
}